Literature DB >> 17052702

Procalcitonin in the diagnosis of inflammation in intensive care units.

Romolo M Dorizzi1, Enrico Polati, Piersandro Sette, Anna Ferrari, Paolo Rizzotti, Aldo Luzzani.   

Abstract

OBJECTIVES: To assess the effectiveness of different procalcitonin cutoff values to distinguish non-infected (negative+SIRS) from infected (sepsis+severe sepsis+septic shock) medical and surgical patients. DESIGN AND METHODS: PCT plasma concentration was measured using an automated chemiluminescence analyzer in 1013 samples collected in 103 patients within 24 h of admission in ICU and daily during the ICU stay. We compared PCT levels in medical and surgical patients. We also compared PCT plasma levels in non-infected versus infected patients and in SIRS versus infected patients both in medical and in surgical groups.
RESULTS: Median values of PCT plasma concentrations were significantly higher in infected than in non-infected groups, both in medical (3.18 vs. 0.45 microg/L) (p<0.0001) and in surgical (10.45 vs. 3.89 microg/L; p<0.0001) patients. At the cutoff of 1 microg/L, the LR+ was 4.78, at the cutoff of 6 microg/L was 12.53, and at the cutoff of 10 microg/L was 18.4.
CONCLUSIONS: This study highlights the need of different PCT cutoff values in medical and surgical critically ill patients, not only at the ICU admission but also in the entire ICU stay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052702     DOI: 10.1016/j.clinbiochem.2006.08.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patients.

Authors:  Yasuko O Erickson; Noelle I Samia; Bruce Bedell; Kenneth D Friedman; Bonnie S Atkinson; Thomas J Raife
Journal:  J Clin Apher       Date:  2009       Impact factor: 2.821

2.  Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay.

Authors:  Iraklis Tsangaris; Diamantis Plachouras; Dimitra Kavatha; George Michael Gourgoulis; Argirios Tsantes; Petros Kopterides; George Tsaknis; Ioanna Dimopoulou; Stylianos Orfanos; Evangelos Giamarellos-Bourboulis; Helen Giamarellou; Apostolos Armaganidis
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

3.  Postoperative pain and systemic inflammatory stress response after preoperative analgesia with clonidine or levobupivacaine: a randomized controlled trial.

Authors:  Jasminka Persec; Zoran Persec; Ino Husedzinovic
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units.

Authors:  Khalid Abidi; Ibtissam Khoudri; Jihane Belayachi; Naoufel Madani; Aicha Zekraoui; Amine Ali Zeggwagh; Redouane Abouqal
Journal:  Crit Care       Date:  2008-04-24       Impact factor: 9.097

5.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study.

Authors:  Sari Karlsson; Milja Heikkinen; Ville Pettilä; Seija Alila; Sari Väisänen; Kari Pulkki; Elina Kolho; Esko Ruokonen
Journal:  Crit Care       Date:  2010-11-15       Impact factor: 9.097

6.  Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis.

Authors:  Tsuneaki Kenzaka; Masanobu Okayama; Shigehiro Kuroki; Miho Fukui; Shinsuke Yahata; Hiroki Hayashi; Akihito Kitao; Eiji Kajii; Masayoshi Hashimoto
Journal:  Int J Gen Med       Date:  2012-05-31

7.  Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.

Authors:  Yong Liu; Jun-Huan Hou; Qing Li; Kui-Jun Chen; Shu-Nan Wang; Jian-Min Wang
Journal:  Springerplus       Date:  2016-12-12

Review 8.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.